Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04693598 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gene Transfer Clinical Trial for Krabbe Disease

Study acronym: RESKUE
StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study Statusv17
  2. Minor Study Statusv16
  3. Minor Study Status, Contacts/Locationsv15
  4. Minor Study Statusv14
  5. Minor Study Statusv13
Show 11 earlier versionsHide 11 earlier versions
  1. Minor Trial status: Recruiting to Active, Not Recruitingv12
  2. Minor Study Status, Outcome Measures, Eligibility, Contacts/Locationsv11
  3. Notable Trial status: Active, Not Recruiting to Recruitingv10
  4. Minor Study Status, Study Description, Outcome Measures, Eligibility, Contacts/Locationsv9
  5. Minor Trial status: Recruiting to Active, Not Recruitingv8
  6. Minor Study Status, Contacts/Locationsv7
  7. Minor Study Status, Contacts/Locationsv6
  8. Notable Trial status: Not Yet Recruiting to Recruitingv5
  9. Minor Study Status, Outcome Measuresv4
  10. Minor Study Status, Outcome Measures, Contacts/Locationsv3
  11. Minor Study Status, Study Design, Outcome Measuresv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a nonblinded, non-randomized dose escalation study of intravenous AAVrh10 after hematopoietic stem cell transplantation (HSCT) in which subjects will receive standard of care hematopoietic cell transplantation for Krabbe disease, followed by a single infusion of an adeno-associated virus gene therapy product. Extensive natural history subjects will be used to compare as control group.
Trial Details
NCT Number NCT04693598
Lead Sponsor Forge Biologics, Inc
Conditions
(from sponsor)
Krabbe Disease
Related terms Leukodystrophy, Globoid Cell, Lysosomal Storage Diseases
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov